Growth Is Not Always Value

The Hidden Cost of Healthcare Expansion

Growth is one of the most celebrated signals of success in healthcare.

More clinics.

More specialties.

More physicians.

More revenue.

But what if the organization is growing financially while becoming harder to lead?

A new location may generate revenue yet require disproportionate executive attention. A specialty expansion may attract patients while drawing scarce specialists away from higher-value services. A new service line may look profitable while increasing demands on scheduling, compliance, technology, finance, and clinical governance.

The revenue is visible. The organizational cost is often dispersed across departments—and therefore easier to overlook.

The uncomfortable question for healthcare leaders is this: Are we measuring what growth earns—or what it forces the rest of the organization to absorb?

When Growth Creates an Enterprise-Wide Bill

Consider a healthcare group opening another clinic in the UAE. The business case projects patient volumes, staffing costs, and expected revenue. Yet the existing leadership team must also supervise another operation, the compliance function must support another site, and central services must absorb additional complexity.

None of these demands may appear fully in the new clinic’s profit-and-loss statement.

The same pattern occurs when organizations add specialties, expand operating hours, or introduce technology across multiple facilities. Growth can consume the very resources needed to maintain performance elsewhere.

Three costs deserve particular scrutiny:

• Leadership capacity: How much CEO, COO, and medical leadership time is diverted from enterprise priorities to stabilize expansion?

• Scarce expertise: Are experienced clinicians, managers, and specialists being stretched across more activities without a corresponding increase in effective capacity?

• Organizational complexity: What additional coordination, reporting, technology, compliance, and decision-making does each new layer of growth require?

These costs are not necessarily reasons to reject expansion. They are reasons to assess it more rigorously.

The Margin Can Mislead

A new service line may report an attractive contribution margin because shared infrastructure and management support are paid for elsewhere. A new clinic may meet its revenue target while requiring substantial intervention from senior leaders. A successful expansion may even weaken performance at an established location by diverting key personnel.

This is how growth can create a misleading picture: the new activity appears successful in isolation, while the organization absorbs the cost.

Research on corporate growth and organizational complexity offers a useful caution. In The Innovator’s Dilemma (1997), Clayton M. Christensen examined how established organizations can become constrained by the structures and priorities that support their existing businesses. Although his focus was disruptive innovation, the broader leadership lesson is relevant: what sustains the current operating model may not be sufficient for a more complex future.

Healthcare executives should therefore ask not only whether an expansion can generate revenue, but whether the organization can support it without weakening the performance of the wider system.

Five Questions Before the Next Expansion

Before approving a new clinic, specialty, or major growth initiative, CEOs and boards should ask:

1. What will this growth consume beyond its direct budget? Include executive time, shared services, scarce expertise, and infrastructure.

2. Which existing priorities will lose capacity? Every expansion competes with something—even when that trade-off is not documented.

3. Can the current leadership structure absorb the additional complexity? Or will growth create a permanent need for senior intervention?

4. Does the business case capture the full enterprise cost? Examine where costs are recorded, where benefits accrue, and which functions quietly subsidize the initiative.

5. Will this expansion make the organization stronger—or simply larger? Consider resilience, quality, operational consistency, and the ability to execute future priorities.

These questions shift the discussion from “Can we grow?” to “Can we create value from growth without weakening the enterprise?”

Build the Capacity Before You Need It

Sustainable growth requires more than a compelling market opportunity. It requires leadership systems, management capacity, decision clarity, and infrastructure that can scale with the business.

That means assessing organizational readiness before expansion, making shared costs visible, identifying constraints early, and agreeing how success will be measured beyond revenue. It also means monitoring whether growth is creating value across the enterprise—not merely meeting the targets of the newest initiative.

Phoenix MedStrategy helps healthcare leaders evaluate growth decisions through both financial and organizational lenses, identifying hidden constraints before they become expensive performance problems.

The executive test is simple: Are you measuring what growth earns—or what it forces the rest of the organization to absorb?

Because a healthcare organization can become larger without becoming stronger.

The objective is not growth at any cost. It is growth that builds enduring value.

Sources

Christensen, Clayton M. The Innovator’s Dilemma: When New Technologies Cause Great Firms to Fail. Harvard Business School Press, 1997.

Kaplan, Robert S., and David P. Norton. The Balanced Scorecard: Translating Strategy into Action. Harvard Business School Press, 1996.

Porter, Michael E. “What Is Strategy?” Harvard Business Review, November–December 1996.